KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Cash & Equivalents (2016 - 2026)

Exelixis (EXEL) has 17 years of Cash & Equivalents data on record, last reported at $482.5 million in Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 121.96% year-over-year to $482.5 million; the TTM value through Jan 2026 reached $482.5 million, up 121.96%, while the annual FY2026 figure was $482.5 million, 121.96% up from the prior year.
  • Cash & Equivalents reached $482.5 million in Q1 2026 per EXEL's latest filing, up from $376.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $723.3 million in Q2 2022 and bottomed at $164.4 million in Q3 2025.
  • Average Cash & Equivalents over 5 years is $395.8 million, with a median of $386.6 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: tumbled 57.27% in 2024, then skyrocketed 121.96% in 2026.
  • A 5-year view of Cash & Equivalents shows it stood at $501.2 million in 2022, then tumbled by 47.53% to $263.0 million in 2023, then fell by 1.77% to $258.3 million in 2024, then surged by 45.66% to $376.3 million in 2025, then grew by 28.22% to $482.5 million in 2026.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $482.5 million in Q1 2026, $376.3 million in Q4 2025, and $164.4 million in Q3 2025.